Device Trial Radar · NCT07651852
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Oct 9, 2026
Primary completion
Oct 2029
Study completion Oct 2029
Sponsor
- Lead sponsor
- Kardium Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 16, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).
Conditions
- Atrial Fibrillation
Interventions
Globe Pulsed Field SystemDevice
Ablation and atrial mapping with the Globe Pulsed Field System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effectiveness endpointTime frame: 12 months
- Safety endpointTime frame: 7 days
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Arrhythmia Research Group
Jonesboro, Arkansas · Recruiting
Overlake Hospital
Bellevue, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.